Evidence Hub

The role of non-coding RNAs in the pathogenesis of migraine: from molecular insights to potential biomarkers

Zhang L, Wang D, Wang W, Chen J, Qian H, Ruan Y

Frontiers in neurology, 2026

Abstract

Non-coding RNAs (ncRNAs) have emerged as critical post-transcriptional regulators in migraine pathophysiology, yet their clinical translational potential remains incompletely defined. This narrative review synthesizes current evidence on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in migraine, organizing findings around a "mechanism-biomarker-intervention" framework. Key findings include: (1) multiple miRNAs (e.g., miR-155, miR-34a-5p, miR-342-3p) are differentially expressed in peripheral blood mononuclear cells (PBMCs) or serum of migraine patients, with expression patterns correlating with attack phase, chronicity, and treatment response to CGRP-targeted therapies; (2) the lncRNA NEAT1 regulates photophobic behavior via the miR-196a-5p/Trpm3 axis in preclinical models, though evidence derives exclusively from male mice-a significant limitation given the 3:1 female-to-male prevalence ratio of migraine; (3) recent studies have begun to provide direct evidence for circRNA involvement in migraine, including differential circRNA expression profiles in patient PBMCs and functional characterization of hsa_circ_0006168 in promoting central sensitization; and (4) lncRNAs PVT1 and MEG3 show differential expression between migraine with and without aura, suggesting subtype-specific biomarker potential. However, the field faces substantial challenges: most studies employ small, cross-sectional designs; biological matrices are inconsistently…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free